Federal Register / Vol. 79, No. 67 / Tuesday, April 8, 2014 / Notices 19339 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2014–0003] 

Draft Guideline—Centers for Disease 

Control and Prevention Draft Guideline 

for the Prevention of Surgical Site 

Infections 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (DHHS). 

ACTION: Reopening of public comment 

period. 

SUMMARY: On January 29, 2014 the 

Centers for Disease Control and 

Prevention (CDC), located within the 

Department of Health and Human 

Services (HHS) published a notice in the 

Federal Register requesting public 

comment on the Draft Guideline for the 

Prevention of Surgical Site Infections 

(SSIs) (draft Guideline) (79 FR 4724). 

Written comments were to be received 

on or before February 28, 2014. Some 

commenters requested additional time 

to review the guideline and provide 

comments. In consideration of these 

requests, HHS/CDC is reopening the 

comment period for 30 days. 

DATES: Comments must be received on 

or before May 8, 2014. 

ADDRESSES: You may submit comments, 

identified by CDC–2014–0003, by any of 

the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Division of Healthcare Quality 

Promotion, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Centers for Disease Control 

and Prevention, Attn: Guideline for the 

Prevention of Surgical Site Infections 

Docket No. CDC–2014–0003, 1600 

Clifton Rd. NE., Mailstop A07, Atlanta, 

Georgia, 30333. 

Instructions: All submissions received 

must include the agency name and 

docket number or RIN. All relevant 

public comments received will be 

posted publicly to www.regulations.gov 

without change, including any personal 

or proprietary information provided. To 

download an electronic version of the 

draft Guideline and appendices, access 

http://www.regulations.gov. 

Written materials identified by Docket 

No. CDC–2014–0003 will be available 

for public inspection Monday through 

Friday, except for legal holidays, 9 a.m. 

until 4:30 p.m. Eastern Standard Time, 

at CDC Library, 1600 Clifton Road NE., 

Atlanta, Georgia, 30333. Please call 

ahead to (404) 639–1717 and request a 

Library representative schedule your 

visit. All public comments will be 

reviewed and considered prior to 

finalizing the draft Guideline. 

FOR FURTHER INFORMATION CONTACT: Erin 

Stone, Division of Healthcare Quality 

Promotion, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE., 

Mailstop A–31, Atlanta, Georgia, 30333; 

Telephone: (404) 639–4000. 

SUPPLEMENTARY INFORMATION: The draft 

Guideline addresses new and updated 

strategies for the prevention of SSI in 

healthcare settings. This draft Guideline 

can be found at http://

www.regulations.gov Docket No. CDC– 

2014–0003. 

CDC also published the supporting 

appendices that include primary 

evidence, study evaluation, and data 

evaluation tables that were used in 

developing the draft Guideline 

recommendations. 

The draft Guideline is designed for 

use by infection prevention staff, 

healthcare epidemiologists, 

administrators, nurses, and personnel 

responsible for developing, 

implementing, and evaluating infection 

prevention and control programs for 

healthcare settings across the 

continuum of care. The 

recommendations contained in the draft 

Guideline are based on a targeted 

systematic review of the best available 

evidence for specific topics related to 

the prevention of surgical site infections 

(SSI). 

Since 2010 CDC has collaborated with 

national partners, academicians, public 

and private health professionals, and 

other partners to create this draft 

Guideline. Additionally, CDC sought 

input in each phase of development 

from subject matter experts in surgery, 

infectious diseases, and orthopedics 

through a Guideline Expert Panel 

formed to develop the new draft 

Guideline. CDC also received input from 

the Healthcare Infection Control 

Practices Advisory Committee (HICPAC) 

throughout the development of the draft 

Guideline. HICPAC includes 

representatives from public health, 

infectious diseases, regulatory and other 

federal agencies, professional societies, 

and other stakeholders. This new draft 

Guideline will not be a federal rule or 

regulation. 

Dated: April 3, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2014–07783 Filed 4–7–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Surveillance and Research of 

Muscular Dystrophies and 

Neuromuscular Disorders, FOA DD14– 

001, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

9:00 a.m.–6:00 p.m., April 22, 2014 

(Closed) 

9:00 a.m.–6:00 p.m., April 23, 2014 

(Closed) 

9:00 a.m.–6:00 p.m., April 24, 2014 

(Closed) 

Place: Teleconference 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters For Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Surveillance and Research of Muscular 

Dystrophies and Neuromuscular 

Disorders, FOA DD14–001, initial 

review.’’ 

Contact Person For More Information: 

M. Chris Langub, Ph.D., Scientific 

Review Officer, CDC, 4770 Buford 

Highway NE., Mailstop F–80, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

3585, EEO6@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–07776 Filed 4–7–14; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES